Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$825K Sell
3,675
-168
-4% -$41.9K 0.11% 134
2025
Q4
$926K Sell
3,843
-150
-4% -$38.4K 0.12% 114
2025
Q3
$1.09M Buy
3,993
+24
+0.6% +$6.56K 0.15% 104
2025
Q2
$1.02M Buy
3,969
+183
+5% +$43.7K 0.16% 102
2025
Q1
$847K Buy
3,786
+113
+3% +$26.4K 0.15% 107
2024
Q4
$840K Buy
3,673
+143
+4% +$34.4K 0.14% 106
2024
Q3
$862K Buy
3,530
+300
+9% +$67K 0.15% 99
2024
Q2
$618K Buy
3,230
+368
+13% +$74.7K 0.12% 118
2024
Q1
$567K Buy
2,862
+384
+15% +$70.4K 0.13% 120
2023
Q4
$426K Buy
2,478
+172
+7% +$26.4K 0.12% 125
2023
Q3
$341K Buy
2,306
+205
+10% +$37.1K 0.11% 137
2023
Q2
$459K Buy
2,101
+274
+15% +$61.1K 0.16% 103
2023
Q1
$400K Sell
1,827
-49
-3% -$10.6K 0.17% 101
2022
Q4
$390K Buy
1,876
+202
+12% +$44.4K 0.2% 92
2022
Q3
$365K Buy
1,674
+131
+8% +$29.8K 0.22% 81
2022
Q2
$323K Sell
1,543
-150
-9% -$31.9K 0.2% 89
2022
Q1
$411K Sell
1,693
-28
-2% -$6.77K 0.24% 91
2021
Q4
$448K Buy
+1,721
New +$447K 0.25% 84

Other funds holding RMD

Wahed Invest's RMD Position: Q1 2026 in Review

Wahed Invest reduced its ResMed (RMD) stake by 4.4% in Q1 2026, selling an estimated $41.9K and leaving 3,675 shares worth $825K. The position accounts for 0.11% of the portfolio, ranked #134.

Wahed Invest first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.09M in Q3 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Wahed Invest held 3,675 shares of ResMed worth $825K as of Q1 2026.
  • Wahed Invest sold 168 ResMed shares in Q1 2026, an estimated $41.9K.
  • ResMed made up 0.11% of Wahed Invest's portfolio in Q1 2026, its #134 holding.
  • Wahed Invest first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
  • Wahed Invest's ResMed position peaked at $1.09M in Q3 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Wahed Invest's 13F filing for Q1 2026, filed 13 May 2026.